Contrast Media Injectors

Contrast media injectors are used to inject contrast media or contrast agents to enhance the blood and perfusion in tissues.

The global contrast media market size is expected to reach USD 7.2 billion by 2028 and is expected to expand at a CAGR of 8.6% from 2021 to 2028.
News | Contrast Media
Global Contrast Media Trends and Analysis Report 2021

December 30, 2021 — The "Global Contrast Media Market Size, Share & Trends Analysis Report by Product Type (Iodinated ...

Time December 30, 2021
arrow
Qaelum NV announced that they enter into a strategic partnership with ulrich GmbH & Co. KG in Ulm to combine their advanced Contrast Management solution with the contrast media injectors of ulrich medical, to support the needs of hospitals and imaging networks.
News | Contrast Media Injectors
Qaelum NV and ulrich Medical Enter Into a Strategic Partnership

December 13, 2021 — Qaelum NV announced that they enter into a strategic partnership with ulrich GmbH & Co. KG in Ulm to ...

Time December 13, 2021
arrow
Avoiding contrast dyes for imaging tests not necessary if concerned about iodine allergy, peer-reviewed study concludes #MRI
News | Contrast Media Injectors
New Research Shatters Age-old Iodine Allergy Myth

September 16, 2021 — FDB (First Databank), a leading provider of drug and medical device knowledge that helps healthcare ...

Time September 16, 2021
arrow
Sponsored Content | Blog | Contrast Media Injectors
BLOG: Smart Injector Technology Delivers Effective and Efficient Patient Care

Technology advancements are changing consumers’ expectations, driving industries to adapt and evolve, and the healthcare ...

Time April 29, 2021
arrow
The contrast agents global market is expected to grow at a high single digit CAGR from 2020 to 2027 to reach $7,033.5 million by 2027 due to the increasing incidence and prevalence of chronic diseases and demand for diagnostic and interventional radiology procedures, increase in aging population, expansion of contrast agent indications, the growth of medical imaging in the emerging market, increasing research activities and favorable reimbursement
News | Contrast Media
Contrast Media Agents Global Market

Chemical substances that improve the visibility of specific organs, tissues, or blood vessels during a diagnostic or ...

Time May 03, 2021
arrow
Guerbet announced the launch of OptiProtect 3S, a new range of technical services for its injection solutions. OptiProtect 3S is designed to support imaging centers in the daily use and protection of their injection solutions.
News | Contrast Media Injectors
Guerbet Launches OptiProtect 3S

February 25, 2021 — Guerbet announced the launch of OptiProtect 3S, a new range of technical services for its injection ...

Time February 25, 2021
arrow
Steinberg Diagnostic Medical Imaging headquarters.
Sponsored Content | Case Study | Contrast Media Injectors
Steinberg Diagnostic Medical Imaging

Steinberg Diagnostic Medical Imaging (SDMI) was founded 30 years ago and has grown to be one of the largest outpatient ...

Time January 21, 2021
arrow
According to a new research report1 on the contrast media injectors published by MarketsandMarkets, the market was estimated to be $1.3 billion in 2020 and projected to reach $1.9 billion by 2025, at a compound annual growth rate (CAGR) of 7.4 percent over 2020-2025.
Feature | Contrast Media Injectors | By Melinda Taschetta-Millane
2021 Outlook for the Contrast Media Injectors Market

According to a new research report1 on the contrast media injectors published by MarketsandMarkets, the market was ...

Time January 20, 2021
arrow
This novel agent, based on the essential nutrient manganese, has strong potential as a safer alternative to currently used contrast agents
News | Contrast Media
Novel MRI Contrast Agent Sidesteps Toxic Effects of Current Products

December 28, 2020 — Adding a contrast-enhancing agent to magnetic resonance imaging (MRI) significantly improves image ...

Time December 28, 2020
arrow
GE Healthcare has received U.S. FDA approval of its macrocyclic gadolinium-based MRI contrast agent, Clariscan (gadoterate meglumine), in pre-filled syringes. #RSNA20
News | Contrast Media
GE Healthcare Announces U.S. FDA approval of macrocyclic MRI Contrast Agent Clariscan in Pre-Filled Syringes

November 26, 2020 — GE Healthcare has received U.S. FDA approval of its macrocyclic gadolinium-based MRI contrast agent ...

Time November 26, 2020
arrow
Bracco Diagnostics Inc. announced it will be showcasing its full portfolio of diagnostic imaging solutions in an immersive digital experience at the first all-virtual Radiological Society of North America (RSNA) annual meeting being held November 29 through December 5.
News | Contrast Media Injectors
Bracco Showcases Immersive Digital Experience at RSNA20

November 17, 2020 — Bracco Diagnostics Inc. announced it will be showcasing its full portfolio of diagnostic imaging ...

Time November 17, 2020
arrow
Guerbet announced that it will highlight UNIK, a tailored solution for diagnostic imaging, at the 2020 annual meeting of the Radiological Society of North America (RSNA).
News | Contrast Media
Guerbet to Showcase its UNIK Solution at RSNA 2020

November 17, 2020 — Guerbet announced that it will highlight UNIK, a tailored solution for diagnostic imaging, at the ...

Time November 17, 2020
arrow
When new installations are ordered, the DAS team at Bracco matches a specialist with the installation based on specialty, learning style and industry awareness. This approach was helpful at Beaufort Memorial Hospital in Beaufort, S.C., which just recently transitioned to the Bracco EmpowerCTA+ Injector System.
Sponsored Content | Blog | Contrast Media
BLOG: Training and Vendor Support Key to Successful Device Upgrade

Transitioning to a new device vendor can provide improvements to outdated technology and workflow. It also requires a ...

Time October 20, 2020
arrow
the Contrast Media Injectors Market is estimated to be USD 1.3 billion in 2020 and  projected to reach $1.9B by 2025, at a CAGR of 7.4% between 2020 and 2025
News | Contrast Media Injectors
Contrast Media Injectors Market Projected at $1.9 billion by 2025

September 2, 2020 — According to the new market research report "Contrast Media Injectors Market By Product (Injector ...

Time September 02, 2020
arrow
The radiology department uses Bracco’s Empower CTA injector system and has a been a Bracco customer for more than 15 years.
Sponsored Content | Blog | Contrast Media Injectors
BLOG: Reliability and Customer Service Key to Injector Uptime and CT Department Workflow

In a busy hospital imaging department, maintaining high device uptime levels is critical. If an injector malfunctions or ...

Time August 20, 2020
arrow
The global contrast media market is projected to grow at a CAGR of 4.23% to reach US$7,113.91 million by 2025 from US$5,548.19 million in 2019, according to a new report from ResearchandMarkets.com
News | Contrast Media
Global Contrast Media Market Report 2020-2025: $7.1 Billion Industry Assessment

July 22, 2020 — The global contrast media market is projected to grow at a CAGR of 4.23% to reach US$7,113.91 million by ...

Time July 22, 2020
arrow
Guerbet shows its commitment to healthcare professionals with two ranges of consumables selected for their injection solutions
News | Contrast Media Injectors
Guerbet Segments Consumables in Two Essential and Excellence Ranges

June 29, 2020 — Guerbet has launched a new "consumables.guerbet.com" website presenting its Essential and Excellence ...

Time June 29, 2020
arrow
The Global Contrast Injectors Market will grow by $613.47M during 2020-2024, according to Technavio
News | Contrast Media Injectors
Contrast Injectors Market Growth and Trends

June 17, 2020 — Technavio has been monitoring the contrast injectors market and it is poised to grow by $613.47M during ...

Time June 17, 2020
arrow
The FDA has approved Lilly’s TAUVID (flortaucipir F 18 injection), a radioactive diagnostic agent, for PET imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs) in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease
News | Contrast Media
FDA Approves TAUVID for Use in Patients Being Evaluated for Alzheimer’s Disease

June 1, 2020 — TAUVID, a radioactive diagnostic agent, has been approved by the FDA for positron emission tomography ...

Time June 01, 2020
arrow
Sponsored Content | Videos | Contrast Media Injectors
itnTV “Conversations”: Radiology Trends with Bayer’s Dennis Durmis

At this year’s RSNA ITN sat down with Dennis Durmis, Senior Vice President, Bayer Radiology to discuss Radiology trends ...

Time May 22, 2020
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now